New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:27 EDTALNY, KWR, GSVC, FARO, ETM, EPAM, EGHT, CASH, BMTC, AME, CUBIEmerald Advisers to hold a forum
21st Groundhog Day Investment Forum is being held in Philadelphia on Feburary 6.
News For ALNY;AME;BMTC;CASH;EGHT;EPAM;ETM;FARO;GSVC;KWR;CUBI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 22, 2014
16:57 EDTEGHT8x8, Inc. raises FY15 revenue growth view to approximately 26%
Subscribe for More Information
16:52 EDTEGHT8x8, Inc. reports Q2 MMR up 59% YoY
New monthly recurring revenue, MRR, sold by channel and mid-market sales increased 59% year-over-year, representing 44% of new MRR sold in the quarter, compared with 33% in the same period last year.
16:50 EDTEGHT8x8, Inc. reports Q2 service revenue up 30% YoY to $36.1M
Subscribe for More Information
16:12 EDTEGHT8x8, Inc. reports Q2 EPS 5c, consensus 3c
Reports Q2 revenue $39.6M, consensus $39.51M.
October 21, 2014
09:48 EDTALNYShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information
06:37 EDTCUBICustomers Bancorp reports Q3 EPS 42c, consensus 40c
Subscribe for More Information
October 15, 2014
09:57 EDTALNYLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
09:30 EDTEGHT8x8, Inc. upgraded to Buy from Neutral at Sidoti
Subscribe for More Information
October 14, 2014
14:02 EDTCASHMeta Financial to enter insurance premium finance industry with AFS acquisition
Meta Financial Group announced that its bank subsidiary, MetaBank, has signed an agreement with AFS/IBEX Financial Services, or AFS, to acquire substantially all of AFS' loan portfolio and related assets, and hire its team. The proposed purchase, which is subject to customary conditions, has been approved by the boards of each company and is expected to close by the end of the calendar year. As part of the purchase, MetaBank is acquiring approximately $80M of outstanding premium finance receivables and the AFS trade name. MetaBank CEO J. Tyler Haahr said, "After acquisition related expenses, we expect this transaction to be accretive to earnings in the first full year of combined operations. The transaction will be financed with all cash and will not require MetaBank to issue additional shares as the purchased receivables and future growth are expected to replace lower yielding securities on our balance sheet."
08:04 EDTALNYAlnylam presents new ALN-TTRsc Phase 1 trial data
Subscribe for More Information
07:36 EDTGSVCGSV Capital volatility flat on tight seven-month price movement
Subscribe for More Information
07:15 EDTKWRQuaker Chemical initiated with a Hold at Wunderlich
Subscribe for More Information
05:40 EDTALNYTekmira partner Alnylam reports positive clinical data for Patisiran study
Tekmira Pharmaceuticals (TKMR) reported that Alnylam Pharmaceuticals (ALNY) presented six-month clinical data for the ongoing Patisiran Phase II Open Label Extension, or OLE, study in patients with Familial Amyloidotic Polyneuropathy, or FAP. Patisiran is an RNAi therapeutic targeting transthyretin, or TTR, in development for the treatment of TTR-mediated amyloidosis, or ATTR, which is enabled by Tekmira's lipid nanoparticle, or LNP, technology. Alnylam presented data at the American Neurological Association's 2014 Annual Meeting. Results showed a mean 0.95 point decrease in modified Neuropathy Impairment Score at six months in 19 patients with mNIS+7 data available for the current analysis. This decrease in neuropathy progression compares favorably with the 7 to 10 point increase in mNIS+7 at six months that can be estimated from historical data sets in untreated FAP patients with similar baseline characteristics.
05:33 EDTEGHT8x8, Inc. upgraded to Buy from Neutral at B. Riley
Subscribe for More Information
October 13, 2014
16:28 EDTALNYOn The Fly: Closing Wrap
Stocks on Wall Street spent most of today's quiet session see-sawing across the flat-line before dropping sharply in the final hour of trading and closing at their lows. The market opened in negative territory but soon made a move to the upside and appeared ready to break the recent market slide that has seen the S&P lose about 5% of its value. Before the averages gained significant steam, they reversed again and moved back into negative ground. The averages moved in a fairly narrow range for most of the afternoon, before accelerating to the downside with conviction in the final hour of trading. ECONOMIC EVENTS: In the U.S., no economic data of note was reported and banks and bond markets were closed in observance of the Columbus Day holiday. In China, the nation's customs administration reported a trade surplus of about $31B for September. Exports in the month increased 15.3% from a year earlier, beating expectations and making for the biggest monthly increase since February 2013. Imports rose 7%, significantly outpacing the consensus projection for a 2% decline. COMPANY NEWS: The Wall Street Journal reported that CSX (CSX) was approached by a larger rival, Canadian Pacific (CP), about a possible merger. However, Credit Suisse analyst Allison Landry wrote in a note to investors that a merger between the two would not be able to occur, due to high regulatory hurdles. Still, CSX rose $1.76, or 5.88%, to $31.70 following the Journal's report, while Canadian Pacific fell $4.40, or 2.32%, to $184.97... Shares of Fiat Chrysler Automobiles (FCAU) made their debut on the New York Stock Exchange and opened at $9 per share. The stock of the newly merged company closed trading down about 1% at $8.92... J.C. Penney (JCP) selected Marvin Ellison, who is currently executive vice president of stores at Home Depot (HD), to become its next CEO. The stock, which was also downgraded to Sell from Neutral at UBS this morning, spent much of the trading day in positive ground but moved lower late in the session and closed down 3c, or 0.42%, at $7.09. MAJOR MOVERS: Among the notable gainers was Alnylam (ALNY), which advanced $13.83, or 18.98%, to $86.68 after the company announced data from study of its treatment for patients with familial amyloidotic polyneuropathy and Piper Jaffray raised its price target on the stock to $133 from $101 citing the trial results. Among the noteworthy losers was AutoNation (AN), which fell $4.11, or 8.01%, to $47.21 after another company in the same sector, Lithia Motors (LAD), lowered its profit outlook for the third and fourth quarter and issued a lower than expected earnings forecast for fiscal 2015. Shares of Lithia, meanwhile, plunged $16.85, or 20.84%, to $64.01. Also lower were shares of GoPro (GPRO), which fell $8.38, or 9.85%, to $76.67 after a French journalist reported that the son of racing legend Michael Schumacher attributed the severity of his father's brain injury following a skiing accident on the GoPro camera mounted to his helmet. INDEXES: The Dow fell 223.03, or 1.35%, to 16,321.07, the Nasdaq dropped 62.58, or 1.46%, to 4,213.66, and the S&P 500 declined 31.39, or 1.65%, to 1,874.74.
09:44 EDTALNYAlnylam price target raised to $133 on positive Ph. 2 results at Piper Jaffray
Piper Jaffray raised Alnylam's price target to $133 from $101 following positive Phase 2 open-label extension study with patisiran in patients with familial amyloidotic polyneuropathy.
07:33 EDTALNYAmerican Neurological Association to hold annual meeting
ANA 2014: 139th Annual Meeting is being held in Baltimore on October 12-14.
07:12 EDTALNYOligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
06:44 EDTALNYAlnylam to host conference call
Subscribe for More Information
06:04 EDTALNYAlnylam's patisiran for polyneuropathy shows positive Phase 2 results
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use